JFL Life Sciences Ltd.
Snapshot View

View in App

Prices View details >>

37.00 -3.60 ▼-8.9%

27 January 2023, 03:51:58 PM
Volume: 6,000

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jfllifesciences.com
Market Cap 40.69 Cr.
Enterprise Value(EV) 57.47 Cr. 2021-03
Financial Indicators
Earnings per share (EPS) 0.49 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 75.07 Trailing Twelve Months Ending 2021-03
Industry PE 32.90 Trailing Twelve Months Ending 2021-03
Book Value / Share 29.61 Trailing Twelve Months Ending 2021-03
Price to Book Value 1.25 Calculated using Price: 37.00
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.10 Cr. 10,998,441 Shares
FaceValue 10
Company Profile
No Company Profile found.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-8.87%
1 Week
-14.94%
1 Month
+8.82%
3 Month
-21.11%
6 Month
1 Year
2 Year
5 Year
10 Year

Ratios View Details >>

3 years 2019-03 2020-03 2021-03
Return on Equity (%) 6.03 6.94 8.85
Return on Capital Employed (%) 8.71 11.80 10.32
Return on Assets (%) 1.87 1.78 2.03

Balance Sheet View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 5 5 7
Non Curr. Liab. 3 1 8
Curr. Liab. 8 18 14
Minority Int.
Equity & Liab. 16 24 29
Non Curr. Assets 3 6 9
Curr. Assets 14 18 20
Misc. Exp. not W/O
Total Assets 16 24 29

Profit Loss View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 32 30 33
Other Income 0 0
Total Income 32 30 33
Total Expenditure -30 -28 -31
PBIDT 1 2 2
Interest -1 -1 -1
Depreciation 0 0 0
Taxation 0 0 0
Exceptional Items
PAT 0 0 1
Adjusted EPS 1 1 1

Cash Flow View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. -3 3 -6
Cash Fr. Inv. -1 -3 -2
Cash Fr. Finan. 4 0 7
Net Change 0 0
Cash & Cash Eqvt 0 0 0

Shareholding Pattern View Details >>

2 Qtrs 2022-09 (%) 2022-12 (%)
Promoter 67.47 67.47
Public 32.53 32.53
Depository Receipts 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00

Announcements View Details >>

No Corporate Announcement found.

Technical Scans View Details >>

Fri, 27 Jan 2023
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
Close Below Last Week Low Close Below Last Week Low
High Increase in 1 Month High Increase in 1 Month
High Decrease in 3 Months High Decrease in 3 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On JFL Life Sciences Ltd.

What is JFL Life Sciences share price?
Can I buy JFL Life Sciences shares now?
What is the Market Cap of JFL Life Sciences?
What are the key metrics to analyse JFL Life Sciences?
What is the 52 Week High and Low of JFL Life Sciences?
What is the trend of JFL Life Sciences share price?